Diagnosis of Variceal Bleeding and Its Control in Cirrhosis

This study has been terminated.

First Received: September 12, 2005 Last Updated: January 18, 2006 History of Changes

Sponsored by:	University Hospital, Angers
Information provided by:	University Hospital, Angers
ClinicalTrials.gov Identifier:	NCT00188097

Purpose

The aim of the study was to determine the independent predictors of variceal bleeding and control of bleeding in cirrhosis as no scientific assessment have been perfomed until now

Condition	Intervention
Cirrhosis	Behavioral: Diagnosis of variceal bleeding and dits control in cirrhosis

MedlinePlus related topics: Cirrhosis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Non-Randomized, Open Label, Historical Control, Single Group Assignment
Official Title:	Diagnosis of Variceal Bleeding and Its Control in Cirrhosis

Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:

variceal bleeding

Estimated Enrollment:	400
Study Start Date:	November 1999
Estimated Study Completion Date:	June 2002

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Cirrhotic patients admitted for an acute complication of cirrhosis
admission ≤ 6 hours of inclusion

Exclusion Criteria:

Child-Pugh score > 13
Digestive hemorrhage
Non cirrhotic portal hypertension

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188097

Sponsors and Collaborators

University Hospital, Angers

Investigators

Principal Investigator:

Paul Cales, PHD

UH Angers

More Information

No publications provided

Study ID Numbers:	PHRC 03-04
Study First Received:	September 12, 2005
Last Updated:	January 18, 2006
ClinicalTrials.gov Identifier:	NCT00188097 History of Changes
Health Authority:	France : Ministery of Health

Study placed in the following topic categories:

Liver Diseases
Digestive System Diseases
Fibrosis
Liver Cirrhosis
Hemorrhage

Additional relevant MeSH terms:

Liver Diseases
Pathologic Processes
Digestive System Diseases
Fibrosis
Liver Cirrhosis

ClinicalTrials.gov processed this record on May 07, 2009